Jaqueline Mendes de Oliveira graduated with a degree in Biochemical Pharmacy from the Federal University of Alfenas (1988), master's and doctorate in Parasitic Biology from the Oswaldo Cruz Institute, Fiocruz (1995 and 2000), with extension (PROBRAL - CAPES/ DAAD) at the Institut für Virologie, Universitätsklinikun Essen, Germany. He has been a technologist at Fundação Oswaldo Cruz since 1996, he has worked at the Viral Hepatitis Laboratory of Instituto Oswaldo Cruz, where he worked in research lines in viral hepatitis, with emphasis on hepatitis C virus (HCV): molecular biology methods applied to diagnosis and monitoring of antiviral therapy. Currently, he works in research areas related to reference diagnosis and epidemiological surveillance, with emphasis on hepatitis A (HAV) and hepatitis E (HEV) viruses, and studies of the immunopathogenesis of viruses using PNH models, at the Technological Development Laboratory in Virology, Instituto Oswaldo Cruz / Fiocruz, where he held the leadership position from 2018 to June 2021.
Jaqueline Mendes de Oliveira graduated with a degree in Biochemical Pharmacy from the Federal University of Alfenas (1988), master's and doctorate in Parasitic Biology from the Oswaldo Cruz Institute, Fiocruz (1995 and 2000), with extension (PROBRAL - CAPES/ DAAD) at the Institut für Virologie, Universitätsklinikun Essen, Germany. He has been a technologist at Fundação Oswaldo Cruz since 1996, he has worked at the Viral Hepatitis Laboratory of Instituto Oswaldo Cruz, where he worked in research lines in viral hepatitis, with emphasis on hepatitis C virus (HCV): molecular biology methods applied to diagnosis and monitoring of antiviral therapy. Currently, he works in research areas related to reference diagnosis and epidemiological surveillance, with emphasis on hepatitis A (HAV) and hepatitis E (HEV) viruses, and studies of the immunopathogenesis of viruses using PNH models, at the Technological Development Laboratory in Virology, Instituto Oswaldo Cruz / Fiocruz, where he held the leadership position from 2018 to June 2021.